clinical trial · NCT06611033
A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)
Merck Sharp & Dohme LLC·phase1·completed·n = 65
HealthyV118CV118PREVNAR 20™Saline
brief summary
The goal of this study is to learn how safe V118 Formulation C is in Healthy Adults and how well people tolerate it.
started
Sep 25, 2024
primary completion
Jan 9, 2026
completion
Jan 9, 2026
last updated
Jan 20, 2026
official title
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation C in Healthy Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol